Editor
Two influential congressional committees on Wednesday passed bills aimed at reigning in pharmacy benefit managers’ operations, signaling that lawmakers’ scrutiny of the prescription middlemen is here to stay.
With the Senate Finance and House Ways and Means committees’ action, every congressional committee focused on healthcare has now passed proposals to increase oversight of PBMs, which negotiate prescription prices with drugmakers…
